ArriVent BioPharma, Inc. AVBP Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$43.32M+32.7% | -$35.54M-72.3% | -$34.98M-70.1% | -$31.4M-43.5% | -$64.39M-270% | ||
| -$559K+26.1% | -$756.5K— | -$756.5K— | -$756.5K— | -$756.5K— | ||
| $5.49M+142% | $3.22M+238% | $3.72M+329% | $3.31M+333% | $2.27M+263% | ||
| -$41.89M+38.4% | -$30.66M-89.8% | -$35.8M-119% | -$26.12M-36.9% | -$68.01M-265% | ||
| $3.58M-90.3% | -$71.2M-48.0% | -$50.76M-5.5% | $13.91M+129% | $36.82M+177% | ||
| $54.87M+712% | $34.73M+63,036% | $86.47M+16,183% | $75.11M+20,593% | $6.76M-96.4% | ||
| $16.56M+168% | -$67.13M+67.8% | -$93K— | $62.9M— | -$24.43M-115% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ArriVent BioPharma, Inc. generate?
- ArriVent BioPharma, Inc. (AVBP) generated -$134.5M in operating cash flow over the trailing twelve months.
- Where does ArriVent BioPharma, Inc.'s cash flow data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.